Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Lars Lannfelt
Person

Lars Lannfelt

Tracked across 3 events · 29 articles · First seen May 08, 2026 · Last active May 28, 2026

Sentiment
2
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 5
Business
BioArctic Annual General Meeting Resolutions
BioArctic AB (publ) held its Annual General Meeting in Stockholm on May 28, 2026, where several key resolutions were made. The meeting adopted the income statement and balance sheet for 2025 and approved a dividend…
Impact: Lars Lannfelt was re-elected as an ordinary board member of BioArctic.
May 28, 2026 · 9 articles
4 0
Business
Eisai Projects Leqembi Revenue Growth
Impact: Professor Lars Lannfelt's discovery of the Arctic mutation in Alzheimer's disease formed the basis for the development of Lecanemab by BioArctic.
May 15, 2026 · 6 articles
4 0
Regulatory
Leqembi Iqlik PDUFA Date Extended
May 08, 2026 · 14 articles
Relationships (2)
BioArctic ↔ Lars Lannfelt
BioArctic ↔ Lars Lannfelt
NEWSDESK
Track Lars Lannfelt live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.